Vestal Point Capital, LP Day One Biopharmaceuticals, Inc. Transaction History
Vestal Point Capital, LP
- $1.9 Trillion
- Q2 2025
A detailed history of Vestal Point Capital, LP transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Vestal Point Capital, LP holds 3,000,000 shares of DAWN stock, worth $22.4 Million. This represents 1.03% of its overall portfolio holdings.
Number of Shares
3,000,000
Previous 2,598,127
15.47%
Holding current value
$22.4 Million
Previous $20.6 Billion
5.35%
% of portfolio
1.03%
Previous 1.47%
Shares
5 transactions
Others Institutions Holding DAWN
# of Institutions
188Shares Held
69.3MCall Options Held
127KPut Options Held
85.5K-
Atlas Venture Life Science Advisors, LLC6.43MShares$48 Million9.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.18MShares$46.1 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$33.9 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA4.1MShares$30.6 Million0.01% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.72MShares$27.8 Million0.56% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $549M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...